Launched on 01/22/2014, the Vident U.S. Equity Strategy ETF (VUSE) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Value category of the market. Market cap ...
When the Food and Drug Administration barred the sale of a brand of menthol e-cigarettes that officials said were a factor in ...
The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...
VUSE was a perennial underperformer, but a January 2023 strategy change provides new hope for shareholders of this all-cap fund with a 0.50% expense ratio. VUSE's current fundamentals are solid ...
"We neither like nor dislike the Fifth Circuit," Suri replied. "What we dislike is for the other side to be able to choose ...
Despite persistent regulatory uncertainty and declining cigarette usage worldwide, the tobacco industry is alive and well in ...
In the final days of President Joe Biden’s term, the US Food and Drug Administration (FDA) has placed a proposal that could ...
BAT Rothmans, the Korean unit of British American Tobacco, announced Tuesday its plans to accelerate growth in the country’s vape market by expanding its product lineup and distribution network. Since ...
It authorised the marketing of three products from RJ Reynolds, under the Vuse brand. The FDA decided that the benefit to adults trying to quit smoking outweighs the risk of teenagers becoming hooked.
The "RIG" portfolio aims for 50% income from defensive sectors and includes 83 stocks across 11+ sectors, focusing on ...